Captrust Financial Advisors Concert Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $270 - $390	-99 Reduced 6.63%	1,394 $5,000
Q4 2021 Feb 14, 2022	SELL	$2.69 - $4.22 $51 - $80	-19 Reduced 1.26%	1,493 $5,000
Q3 2021 Nov 16, 2021	BUY	$3.17 - $4.15 $66 - $87	21 Added 1.41%	1,512 $5,000
Q2 2021 Aug 16, 2021	SELL	$3.77 - $5.24 $79 - $110	-21 Reduced 1.39%	1,491 $6,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $2,488 - $6,691	512 Added 51.2%	1,512 $8,000
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $7,800 - $11,520	1,000 New	1,000 $10,000
Q1 2019 May 15, 2019	SELL	$12.07 - $17.54 $2,414 - $3,508	-200 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.25 - $16.17 $2,250 - $3,234	200 New	200 $3,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.